Curie Brief
Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
News
The AGA says it's time to rethink endless endoscopies for seniors. New guidance published in Clinical Gastroenterology and Hepatology recommends that surveillance for Barrett's esophagus and colorectal conditions in older adults be guided by life expectancy, comorbidities, and patient preferences — not age alone. A supporting large study found that for adults 75+, the risk of dying from non-colorectal causes far outweighs the risk of colorectal cancer itself.
The American Gastroenterological Association (AGA) has released updated clinical practice guidance on surveillance of premalignant conditions — including Barrett's esophagus and colorectal polyps — in older adults. Published in Clinical Gastroenterology and Hepatology, the guidance emphasizes that the decision to continue or stop surveillance should be individualized, weighing life expectancy, comorbidities, procedural risks, and patient preferences rather than applying a one-size-fits-all approach.
The update is backed by a large study of nearly 92,000 US veterans, which found that for adults who reached age 75 cancer-free, the 10-year risk of colorectal cancer death was just 0.5% — dwarfed by a 46–48% risk of dying from other causes. Even among those with a prior adenoma, the absolute cancer risk remained very low across all frailty levels.
By the Numbers
Why it matters: Millions of older Americans are on automatic surveillance recall schedules that may expose them to procedural risks with little benefit. This guidance gives clinicians a framework — and the language — to have honest, compassionate conversations about when stopping surveillance is not giving up, but rather the smarter, patient-centered choice.
